anmelden
FTSE All-Share
5.650,59
PKT
+17,39
PKT
+0,31
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.05.25 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 08.05.25 | BP Buy | Goldman Sachs Group Inc. | |
| 08.05.25 | Unilever Overweight | JP Morgan Chase & Co. | |
| 07.05.25 | BP Neutral | JP Morgan Chase & Co. | |
| 07.05.25 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 07.05.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.05.25 | Diageo Outperform | Bernstein Research | |
| 07.05.25 | Diageo Neutral | JP Morgan Chase & Co. | |
| 07.05.25 | Shell (ex Royal Dutch Shell) Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.05.25 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 06.05.25 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 06.05.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 06.05.25 | BP Sector Perform | RBC Capital Markets | |
| 06.05.25 | Unilever Overweight | JP Morgan Chase & Co. | |
| 02.05.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 02.05.25 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 02.05.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 02.05.25 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
| 02.05.25 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 02.05.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 02.05.25 | London Stock Exchange (LSE) Buy | Goldman Sachs Group Inc. | |
| 02.05.25 | London Stock Exchange (LSE) Overweight | JP Morgan Chase & Co. | |
| 02.05.25 | London Stock Exchange (LSE) Buy | Deutsche Bank AG | |
| 02.05.25 | London Stock Exchange (LSE) Buy | UBS AG | |
| 02.05.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 01.05.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 01.05.25 | London Stock Exchange (LSE) Buy | UBS AG | |
| 01.05.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.05.25 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
| 01.05.25 | Glencore Overweight | Barclays Capital | |
| 01.05.25 | London Stock Exchange (LSE) Buy | Jefferies & Company Inc. | |
| 01.05.25 | Glencore Buy | Goldman Sachs Group Inc. | |
| 01.05.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 01.05.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 01.05.25 | BP Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.05.25 | Glencore Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.05.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.05.25 | HSBC Sector Perform | RBC Capital Markets | |
| 01.05.25 | HSBC Neutral | JP Morgan Chase & Co. | |
| 01.05.25 | GSK Neutral | UBS AG |
